Reminder: First meeting of FDA’s Patient Engagement Advisory Committee

On October 11-12, 2017, the Patient Engagement Advisory Committee will hold its first public meeting to discuss incorporating patient perspectives in the design, conduct and reporting of clinical trials. The Patient Engagement Advisory Committee is the first FDA advisory committee focused wholly on patients and patient-related issues.

The FDA is seeking input from the committee and the public on challenges faced by patients in medical device clinical trials, and recommendations for how patient input and engagement can be used to overcome these challenges.  Members of the committee, including patient representatives, a consumer representative, and a non-voting industry representative (selected based on the topic), provide advice to the Commissioner of the FDA on complex issues relating to medical devices, the regulation of devices, and their use by patients. More information about the advisory committee members and the first meeting is available in the FDA Voice blog post “FDA Sets Inaugural Meeting of First-Ever Patient Advisory Group.”

The FDA is still accepting nominations for future participation on the patient engagement advisory committee. For information about how to nominate yourself or another candidate to participate in the committee please see the Federal Register notice.

For information about the upcoming Patient Engagement Advisory Committee meeting, see theFederal Register notice.

For more information about the committee’s purpose and membership, see the Patient Engagement Advisory Committee webpage. 


Food and Drug Administration
Center for Devices and Radiological Health